ResTorbio pivots pipeline with reverse-merger after trial failure By: Boston Business Journal via Business Journals April 29, 2020 at 14:15 PM EDT Boston biopharma startup resTORbio Inc. is revamping its pipeline to focus on cancer cell therapies through a reverse-merger. Read More >>